$ Value
$185K
Shares
1,190
Price
$155
Filed
Dec 17
Insider
Name
Norwalk Leslie V
Title
—
CIK
0001533568
Roles
Transaction Details
Transaction Date
2025-12-16
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
6,239
Footnotes
The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2025. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. | Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $151.79 to $152.82. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $155.09 to $155.40. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. | The option was granted on May 19, 2021 and vested in 12 equal monthly installments beginning June 19, 2021. | The option was granted on May 18, 2022 and vested in 12 equal monthly installments beginning June 18, 2022.
Filing Info
Norwalk Leslie V's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-21 | GMED | A | $0 |
| 2026-01-08 | GMED | ▼ | $202K |
| 2025-12-16 | NBIX | ▼ | $185K |
| 2025-12-15 | NBIX | M | $764K |
| 2025-12-15 | NBIX | M | $146K |
| 2025-12-15 | NBIX | ▼ | $761K |
| 2025-12-15 | NBIX | M | $0 |
| 2025-12-15 | NBIX | M | $0 |
| 2025-12-12 | GMED | ▼ | $355K |
| 2025-11-20 | CVS | A | $126K |
Other Insiders at NBIX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| GORMAN KEVIN CHARLES | — | — | 2026-02-13 |
|
Lippoldt Darin
Chief Legal Officer
|
— | — | 2026-02-13 |
|
Gano Kyle
Chief Executive Officer
|
— | — | 2026-02-13 |
|
BENEVICH ERIC
Chief Commercial Officer
|
— | — | 2026-02-13 |
|
ABERNETHY MATT
Chief Financial Officer
|
— | — | 2026-03-04 |
|
Cooke Julie
Chief Human Resources Officer
|
— | — | 2026-02-13 |
|
Keswani Sanjay Chandru
Chief Medical Officer
|
— | — | 2026-02-13 |
|
Onyia Jude
Chief Scientific Officer
|
— | — | 2026-02-20 |
|
Boyer David W.
Chief Corp. Affairs Officer
|
— | — | 2026-02-13 |
|
Delaet Ingrid
Chief Regulatory Officer
|
— | — | 2026-02-13 |